Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study

被引：0

作者：

Cortellini, A. ^{[1
]}

Leonetti, A. ^{[2
]}

Parisi, A. ^{[3
]}

Tiseo, M. ^{[4
]}

Bordi, P. ^{[5
]}

Michiara, M. ^{[5
]}

Bui, S. ^{[6
]}

Cosenza, A. ^{[7
]}

Ferri, L. ^{[7
]}

Giudice, G. C. ^{[8
]}

Testi, I. ^{[9
]}

Vincenzi, B. ^{[10
]}

Santo, V. ^{[11
]}

Ricozzi, V. ^{[12
]}

Sgargi, P.

Zustovich, F. ^{[13
]}

Stucci, L. S. ^{[14
]}

Santini, D. ^{[15
]}

Buti, S. ^{[7
]}

Bersanelli, M. ^{[16
]}

机构：

[1] Fdn Policlin Univ Campus Biomed, Med Oncol, Rome, Italy

[2] Osped Maggiore Parma, Dept Med Oncol, Parma, Italy

[3] AOU Osped Riuniti Umberto I GM Lancisi G Salesi, Clin Oncol, Torrette Di Ancona, Italy

[4] Azienda Osped Univ Parma, Dept Med Oncol, Parma, Italy

[5] Osped Maggiore Parma, Med Oncol, Parma, Italy

[6] Univ Hosp Parma, Oncol, Parma, Italy

[7] Univ Parma, Med Oncol, Fac Med & Chirurg, Parma, Italy

[8] Univ Parma, Oncol Med, Parma, Italy

[9] Osped Maggiore Parma, Dept Oncol, Parma, Italy

[10] Policlin Univ Campus Biomed, Dept Med Oncol, Rome, Italy

[11] UCBM Univ Campus Biomed Roma, Oncol Med, Rome, Italy

[12] Policlin Univ Campus Biomed, Med Oncol, Rome, Italy

[13] Osped Belluno, Med Oncol, Belluno, Italy

[14] Policlin Bari Osped Giovanni XXIII, Med Biosci Dept, Bari, Italy

[15] Univ Roma La Sapienza, Oncol Dept, Fac Med, Latina, Italy

[16] Univ Hosp Parma, Dipartimento Oncol Med, Parma, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.907

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2125P

引用

页码：S1110 / S1110

页数：1

共 50 条

[1] Potential role of hypovitaminosis D in renal cell carcinoma patients treated with immune-checkpoint inhibitors.
Bersanelli, Melissa
Vaglio, Augusto
Sverzellati, Nicola
Galetti, Maricla
Incerti, Monia
Parziale, Raffaele
Corrado, Michele
Cosenza, Agnese
Ferri, Leonarda
Leonardi, Francesco
Buti, Sebastiano
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
[2] Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study
Bae, Seongman
Kim, Ye-Jee
Kim, Min-Ju
Kim, Jwa Hoon
Yun, Sung-Cheol
Jung, Jiwon
Kim, Min Jae
Chong, Yong Pil
Kim, Sung-Han
Choi, Sang-Ho
Kim, Yang Soo
Lee, Sang-Oh
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
[3] Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors
Furukawa, Asuka
Tamura, Yuichi
Taniguchi, Hirohisa
Kawamura, Akio
Nagase, Seisuke
Hayashi, Aeru
Tada, Yuichiro
Sase, Kazuhiro
Hatake, Kiyohiko
JOURNAL OF CARDIOLOGY, 2023, 81 (01) : 63 - 67
[4] Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
Chen, Ling
Tan, Hourui
Geng, Ruixuan
Li, Yifan
Wang, Yingyi
Li, Taisheng
THORACIC CANCER, 2025, 16 (01)
[5] Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
Bersanelli, Melissa
Cortellini, Alessio
Leonetti, Alessandro
Parisi, Alessandro
Tiseo, Marcello
Bordi, Paola
Michiara, Maria
Bui, Simona
Cosenza, Agnese
Ferri, Leonarda
Giudice, Giulia Claire
Testi, Irene
Rapacchi, Elena
Camisa, Roberta
Vincenzi, Bruno
Caruso, Giuseppe
Rauti, Antonio Natale
Arturi, Federica
Tucci, Marco
Santo, Valentina
Ricozzi, Valentina
Burtet, Vanessa
Sgargi, Paolo
Todeschini, Renata
Zustovich, Fable
Stucci, Luigia Stefania
Santini, Daniele
Buti, Sebastiano
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3707 - 3716
[6] SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN CANCER PATIENTS WITH CHRONIC HEPATITIS C INFECTION: A PROSPECTIVE OBSERVATIONAL STUDY
Yibirin, Marcel
Pundhir, Pooja
Yepez-Guevara, Eduardo
Granwehr, Bruno
Kaseb, Ahmed
Patel, Sapna
Naing, Aung
Shah, Amishi Y.
Skoulidis, Ferdinandos
Tawbi, Hussein A.
Zhang, Hao Chi
Wang, Lan
Miller, Ethan D.
Torres, Harrys A.
HEPATOLOGY, 2020, 72 : 571A - 572A
[7] Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
Melissa Bersanelli
Alessio Cortellini
Alessandro Leonetti
Alessandro Parisi
Marcello Tiseo
Paola Bordi
Maria Michiara
Simona Bui
Agnese Cosenza
Leonarda Ferri
Giulia Claire Giudice
Irene Testi
Elena Rapacchi
Roberta Camisa
Bruno Vincenzi
Giuseppe Caruso
Antonio Natale Rauti
Federica Arturi
Marco Tucci
Valentina Santo
Valentina Ricozzi
Vanessa Burtet
Paolo Sgargi
Renata Todeschini
Fable Zustovich
Luigia Stefania Stucci
Daniele Santini
Sebastiano Buti
Cancer Immunology, Immunotherapy, 2023, 72 : 3707 - 3716
[8] A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer
Faubry, Clara
Faure, Maxime
Toublanc, Anne-Claire
Veillon, Remi
Lemaitre, Anne-Iris
Vergnenegre, Charlotte
Cochet, Hubert
Khan, Sadia
Raherison, Chantal
Dos Santos, Pierre
Zysman, Maeva
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[9] Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study
Paderi, Agnese
Fancelli, Sara
Caliman, Enrico
Pillozzi, Serena
Gambale, Elisabetta
Mela, Marinella Micol
Doni, Laura
Mazzoni, Francesca
Antonuzzo, Lorenzo
CURRENT ONCOLOGY, 2021, 28 (05) : 3259 - 3267
[10] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
Papaiakovou, Evangelos Eleutherakis
Kastritis, Efstathios
Zagouri, Flora
Grapsa, Dimitra
Ntanassis-Stathopoulos, Ioannis
Stefanou, Dimitra
Evangelou, Georgios
Kotteas, Ilias
Dimopoulos, Meletios A.
Syrigos, Konstantinos
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →